
charles panackel
@drcharliep
Followers
109
Following
226
Media
95
Statuses
664
RT @AnandVKulkarni2: Join us for the 2nd edition of AIG Liver Conclave on 26th and 27th September at Hyderabad . @MajaThiele @gvraoaig @ebt….
0
19
0
RT @JHepatology: 📌In our March issue. Intention-to-treat outcomes of patients with hepatocellular carcinoma receiving immunotherapy before….
0
26
0
RT @ebtapper: What's the deal with Ammonia in hepatic encephalopathy?.A #cirrhosis QI #tweetorial . Aims.Try to answer this question while….
0
387
0
RT @INASL_Liver: Happy Easter.From INASL and INASL-2024, Kochi, Kerala, India.7th - 10th August, 2024.Registration and Abstract Submission….
0
2
0
RT @AnandVKulkarni2: Surgical risk stratification in cirrhosis by Dr Ana Ostomic, @nadimmahmud and Dr Raj Reddy. Which one do you use ? .C….
link.springer.com
Hepatology International - Individuals with cirrhosis experience higher morbidity and mortality rates than the general population, irrespective of the type or scope of surgery. This increased risk...
0
6
0
RT @AnandVKulkarni2: Are we heading towards treat all strategy for HBV? . Congratulations @DrHuangDQ wonderful work. @SengGeeLim1 @docamit….
0
6
0
RT @docMPK: The IF of JCEH is 3 and climbing!.Read comment and write to us. @IJG_Journal @a_c_anand @ajay_duseja @AnandVKulkarni2 @juanpab….
0
8
0
RT @massimoiava: #IMbrave050 is the first phase 3 study of adjuvant treatment for #HCC to report positive results. During @myESMO is out on….
0
19
0
RT @ebtapper: Terrific review of the uses for and uncertainties of albumin infusion in #cirrhosis from THE @ggarciatsao and @JonelTrebicka….
0
70
0
RT @ebtapper: Assessing the risk of surgery in patients with cirrhosis. I find myself referring to this @HepCommJournal paper by Kaltenbach….
0
38
0
RT @jlouissaint89: ✅ out this 💥 Review from @HepCommJournal‼️. 📑 Learn about current and emerging tools for #HCC surveillance🔎! 🧵 .#LiverTw….
0
27
0
RT @ebtapper: Albumin uses, abuses, and future directions in #cirrhosis. ✅.1️⃣SBP.2️⃣after large paracentesis.3️⃣hepatorenal, but don’t ove….
0
80
0